Stock Scorecard



Stock Summary for Bausch Health Companies Inc (BHC) - $10.61 as of 3/28/2024 9:07:00 PM EST

Total Score

6 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for BHC

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BHC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BHC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for BHC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for BHC

Theratechnologies Appoints Jordan Zwick to its Board of Directors 3/22/2024 12:00:00 AM
Theratechnologies Appoints Jordan Zwick to its Board of Directors - Theratechnologies ( NASDAQ:THTX ) 3/22/2024 12:00:00 AM
Is Icahn Enterprises Stock a Buy? 3/16/2024 9:05:00 PM
Why Bausch Health ( BHC ) is a Top Momentum Stock for the Long-Term 3/15/2024 1:50:00 PM
Actinic Keratosis Treatment Market Size is projected to reach USD 9.22 billion by 2031, growing at a CAGR of 4.1%: Straits Research 3/14/2024 2:15:00 PM
We're trimming an embattled portfolio stock facing a binary event that could go either way 2/29/2024 5:14:00 PM
Global Onychomycosis Treatment Market Size is Estimated to Reach USD 4.51 Billion by 2030, Growing at a CAGR of 5.61%: Straits Research 2/29/2024 3:35:00 PM
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick 2/27/2024 2:50:00 PM
Bausch ( BHC ) Q4 Earnings and Revenues Top Estimates 2/23/2024 4:53:00 PM
Looking At Bausch Health Companies's Recent Unusual Options Activity - Bausch Health Companies ( NYSE:BHC ) 2/22/2024 5:15:00 PM

Financial Details for BHC

Company Overview

Ticker BHC
Company Name Bausch Health Companies Inc
Country USA
Description Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology and dermatology. The company is headquartered in Laval, Canada.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/2/2024

Stock Price History

Last Day Price 10.61
Last Day Price Updated 3/28/2024 9:07:00 PM EST
Last Day Volume 3,778,834
Average Daily Volume 2,590,982
52-Week High 10.80
52-Week Low 5.57
Last Price to 52 Week Low 90.48%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE 4.52
Free Cash Flow Ratio 4.10
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 1.30
Total Cash Per Share 2.59
Book Value Per Share Most Recent Quarter -2.80
Price to Book Ratio 18.78
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 0.44
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 365,412,000
Market Capitalization 3,877,021,320
Institutional Ownership N/A

Dividends

Ex-Dividend Date 11/10/2010
Last Dividend Amount 0.10
Current Dividend Amount 1.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 98.45%
3-Year Dividend Growth Rate Percentage -7.62%
5-Year Dividend Growth Rate Percentage 26.49%
All-Time Dividend Growth Rate Percentage 20.68%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 111.50%
Annual Earnings Growth -163.11%
Reported EPS 12 Trailing Months -1.62
Reported EPS Past Year 3.51
Reported EPS Prior Year 3.08
Net Income Twelve Trailing Months -592,000,000
Net Income Past Year -592,000,000
Net Income Prior Year -225,000,000
Quarterly Revenue Growth YOY 9.80%
5-Year Revenue Growth -2.38%

Balance Sheet

Total Cash Most Recent Quarter 947,000,000
Total Cash Past Year 947,000,000
Total Cash Prior Year 564,000,000
Net Cash Position Most Recent Quarter -21,441,000,000
Net Cash Position Past Year -21,441,000,000
Long Term Debt Past Year 22,388,000,000
Long Term Debt Prior Year 20,766,000,000
Total Debt Most Recent Quarter 22,388,000,000
Equity to Debt Ratio Past Year -0.05
Equity to Debt Ratio Most Recent Quarter -0.05
Total Stockholder Equity Past Year -1,022,000,000
Total Stockholder Equity Prior Year -692,000,000
Total Stockholder Equity Most Recent Quarter -1,022,000,000

Options

Put/Call Ratio 0.08
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.29
MACD Signal 0.24
20-Day Bollinger Lower Band 6.34
20-Day Bollinger Middle Band 8.33
20-Day Bollinger Upper Band 10.32
Beta 0.84
RSI 73.77
50-Day SMA 7.99
200-Day SMA 16.29

System

Modified 3/28/2024 7:15:21 PM EST